A new frontier in treating polycystic kidney disease (PKD) has emerged from the labs at the University of California, Santa Barbara. Led by biologist Thomas Weimbs, the team has engineered specialized ...
Background Hereditary haemorrhagic telangiectasia (HHT) and juvenile polyposis syndrome (JPS) can be caused by SMAD4 pathogenic variants. SMAD4 is a common transcription factor of the BMP/TGFβ ...
Two new antibodies may treat autoimmune diseases by reducing inflammation through blocking the immune receptor FcγRI.
An international research group directed by UMC Utrecht has developed and characterized two first-in-class antibodies that ...
Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the ...
A specially engineered antibody that can infiltrate kidney cysts has shown the ability to block key growth signals driving ...
An international research group directed by UMC Utrecht have developed and characterized two first-in-class antibodies that ...
Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the ...
Tiny proteins from camels and llamas, known as nanobodies, offer new hope for brain diseases. These molecules can enter brain ...
Takeda (TSE:4502/NYSE:TAK) today announced new interim data from the Phase 1b, open-label, proof-of-concept study of subcutaneous mezagitamab (TAK-079), an anti-CD38 monoclonal antibody with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback